NIHR and the Office for Life Sciences (OLS) have funded 7 new research projects aimed at bringing new technologies into the NHS to benefit patients. Health innovation provides critical solutions to ...
Virpax announces positive results from minipig Dose Range Finding study for Probudur: Berwyn, Pennsylvania Monday, November 25, 2024, 18:00 Hrs [IST] Virpax Pharmaceuticals, Inc., ...
New Hollings research shows how Golgi stress affects T-cells' tumour-fighting ability: Charleston, South Carolina Monday, November 25, 2024, 17:00 Hrs [IST] The Golgi apparatus mo ...
Clariant introduces new high-performing excipients at the CPHI India 2024 trade show: Our Bureau, Mumbai Monday, November 25, 2024, 16:15 Hrs [IST] Clariant is excited to present ...
Sunshine Biopharma introduces new drug, Ursodiol for management of cholestatic liver diseases, including PBC: Fort Lauderdale, Florida Monday, November 25, 2024, 15:00 Hrs [IST] S ...
Working with week-old zebrafish larva, researchers at Weill Cornell Medicine and colleagues decoded how the connections formed by a network of neurons in the brainstem guide the fishes’ gaze. The ...
Adding a pharmaceutical twist to traditional art forms, Smriti College of Pharmaceutical Education in Indore celebrated 63rd NPW: Our Bureau, Chennai Monday, November 25, 2024, 13 ...
Karnataka health and family welfare department is now augmenting its efforts to use solar energy as a critical strategy to strengthen healthcare delivery in rural areas. This is at a time when ...
China NMPA accepts Akeso's sNDA penpulimab combination therapy for first-line treatment of hepatocellular carcinoma: Hong Kong Monday, November 25, 2024, 13:00 Hrs [IST] Akeso, In ...
BioSurfaces receives $2.06 million grant from Bill & Melinda Gates Foundation to advance development of BSCC device: Ashland, Massachusetts Monday, November 25, 2024, 12:00 Hrs [I ...
Johnson & Johnson seeks US FDA approval for subcutaneous induction regimen of Tremfya in ulcerative colitis: Spring House, Pennsylvania Monday, November 25, 2024, 11:00 Hrs [IST] ...
CON supports new phase II trial of novel pneumococcal vaccine, PnuBioVax: Liverpool Monday, November 25, 2024, 10:00 Hrs [IST ...